Autologous abdominal fat graft transposition for ischemic foot lesion with tendon exposure: a case report and literature review

Authors

  • Ricardo Burciaga Castañeda Hospital ISSSTE Gómez Palacio, Dgo, Mexico
  • Ana Sofia Enriquez Arreola Universidad Juárez del Estado de Durango, Gómez Palacio, Durango, Mexico
  • Miguel Angel Burciaga Castañeda Hospital General 450, Durango, Mexico
  • Jose Humberto López Chávez Hospital ISSSTE Gómez Palacio, Durango, Mexico
  • Maria Del Socorro Nava Hospital Clínico Quirúrgico Hermanos Ameijeiras, Mexico
  • Jaime Sergio Rocha Chong Hospital ISSSTE Gómez Palacio, Durango, Mexico
  • Roberto David Chavez Universidad Autonoma de Coahuila, Torreon, Mexico
  • Gabriela Etelvina Talavera Ramos Hospital Dr. Santiago Ramón y Cajal Dgo, Dgo, Mexico

DOI:

https://doi.org/10.18203/2349-2902.isj20261865

Keywords:

Reconstructive surgery, Autologous fat grafting, Tendon exposure, Graft survival

Abstract

The management of complex wounds such as diabetic foot ulcers, chronic arterial insufficiency lesions, and sacral pressure ulcers is on the rise in recent years due to the chronic nature of these wounds, the potential to become infected, and the difficulty in healing. Microsurgical reconstruction and local flaps are options but may not be possible in patients with significant vascular compromise. The autologous fat grafting has evolved from a simple volume filler to a potent biological modulator because it contains adipose-derived stem cells (ASCs) and growth factors. We discuss the physiologic mechanics of fat grafting and its advantages and disadvantages in the context of complex ischemic lesions.

References

Coleman SR. Structural fat grafting: More than a permanent filler. Plastic Reconstruct Surg. 2006;118(3):108S-20.

Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Engineering. 2001;7(2):211-8.

Rigotti G, Marchi A, Galiè M, Baroni G, Benati D, Krampera M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant. Plastic Reconstruct Surg. 2007;119(5):1409-22.

Cervelli V, Gentile P, Scioli MG, Grimaldi M, Casciani CU, Spagnoli LG, Orlandi A. Application of platelet-rich plasma in plastic surgery: Clinical and in vitro evaluation. Tissue Engineering Part C: Methods. 2009;15(4):625-34.

Gentile P, De Angelis B, Pasin M, Cervelli G, Curcio CB, Floris M, et al. Adipose-derived stromal vascular fraction cells and platelet-rich plasma: Basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofacial Surg. 2014;25(1):267-72.

Kim WS, Park BS, Park SH, Kim HK, Sung JH. Antiwrinkle effect of adipose-derived stem cell: Activation of dermal fibroblast by secretory factors. J Dermatological Sci. 2009;53(2):96-102.

Lee HC, An SG, Lee HW, Park JS, Cha KS, Hong TJ, et al. Safety and effect of adipose-derived stem cell implantation in patients with critical limb ischemia: A pilot study. Circulation J. 2012;76(7):1750-60.

Bura A, Planat-Bénard V, Bourin P, Silvestre JS, Gross F, Grolleau JL, et al. Phase I trial: The use of autologous cultured adipose-derived stem cells to treat patients with nonrevascularizable critical limb ischemia. Cytotherapy. 2014;16(2):245-57.

Moon KC, Suh HS, Kim KB, Han SK, Young KW, Lee JW, et al. Potential of allogeneic adipose-derived stem cell-hydrogel complex for treating diabetic foot ulcers. Diabetes. 2019;68(4):837-46.

Mazini L, Rochette L, Amine M, Malka G. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs). Int J Molecular Sci. 2019;20(10):2523.

Marfia G, Navone SE, Di Vito C, Ughi N, Tabano S, Miozzo M, et al. Mesenchymal stem cells: Potential for therapy and treatment of chronic wounds. Int J Molecul Sci. 2021;22(7):3473.

Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3(4):e1886.

Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292-8.

Lancerotto L, Chin MS, Freniere BB, Krummel TM, Longaker MT, Lorenz HP. Mechanisms of action of adipose-derived stem cells in chronic wounds. Ann Plastic Surg. 2012;69(3):316-21.

Strong AL, Cederna PS, Rubin JP, Coleman SR, Levi B. The current state of fat grafting: A review of harvesting, processing, and injection techniques. Plastic Reconstruct Surg. 2015;136(4):897-912.

Cervelli V, Scioli MG, Gentile P, Doldo E, Bonanno E, Spagnoli LG, Orlandi A. Adult stem cell application in wounds and tissue defects: A systematic review. Stem Cell Res Therapy. 2017;8(1):1-10.

Tseng S, Kang L, Li Z, Wang L, Li Z, Li T, et al. Adipose-derived stem cells in diabetic foot care: Bridging clinical trials and practical application. World J Diabetes. 2024;15(6):1162-77.

Hao Z, Qi W, Sun J, Zhou M, Guo N. Review: Research progress of adipose-derived stem cells in the treatment of chronic wounds. Frontiers Chem. 2023;11:1094693.

Liu Z, Li Y, Zhao J, Li Q, Ren J, Wang G. The role of adipose-derived stem cells in the treatment of chronic wounds: A systematic review. Int J Molecul Sci. 2022;23(4):1538.

Downloads

Published

2026-06-18

How to Cite

Castañeda, R. B., Arreola, A. S. E., Castañeda, M. A. B., Chávez, J. H. L., Nava, M. D. S., Chong, J. S. R., Chavez, R. D., & Ramos, G. E. T. (2026). Autologous abdominal fat graft transposition for ischemic foot lesion with tendon exposure: a case report and literature review. International Surgery Journal. https://doi.org/10.18203/2349-2902.isj20261865

Issue

Section

Case Reports